As most of you probably know, biotechnology company Serono, based in Geneva, Switzerland, agreed in October to pay $704 million to the United States federal government to settle charges that it illegally marketed its AIDS drug Serostim. According...
There has been a frenzy of activity in recent months with seemingly everyone involved in CME seeking to avoid negative publicity or to assure that their organizations are protected from official sanction from the Accreditation Council for CME...
CME providers agonize over eliminating the possible perception of bias in their activities due to pharmaceutical industry support, but are docs similarly concerned — and if so, are they concerned enough to pay their own way? For the first time...
I Recently Attended the American Heart Association annual meeting in Dallas. It was an impressive event — more than 27,000 attendees took over most of the city for five full days. The exhibit hall was inspirational, with pharmaceutical companies...
I think my favorite moment at this year's Annual Conference of the National Task Force on CME Provider/Industry Collaboration was when Gardiner Harris, a scientific reporter for The New York Times, said, “But can't the commercial supporter view a...
Meeting Professionals International has come on board as the educational sponsor for the Second Annual Pharmaceutical Meeting Planners Forum, and will provide CEUs for attendees. Organized by Medical Meetings and the Center for Business...